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The aims of this study were to evaluate the chemical profile, vascular reactivity, and acute hypotensive 
effect (AHE) of the ethanolic extract of leaves of Alpinia purpurata (Vieill) K. Schum (EEAP). Its 
chemical profile was evaluated using HPLC-UV, ICP-OES, and colorimetric quantification of total 
flavonoids and polyphenols. The vascular reactivity of the extract was determined using the mesenteric 
bed isolated from WKY. AHE dose-response curves were obtained for both EEAP and inorganic material 
isolated from AP (IAP) in WKY and SHR animals. Cytotoxic and mutagenic safety levels were determined 
by the micronucleus test. Rutin-like flavonoids were quantified in the EEAP (1.8 ± 0.03%), and the total 
flavonoid and polyphenol ratios were 4.1 ± 1.8% and 5.1 ± 0.3%, respectively. We observed that the 
vasodilation action of EEAP was partially mediated by nitric oxide (·NO). The IAP showed the presence 
of calcium (137.76 ± 4.08 μg mg-1). The EEAP and IAP showed an AHE in WKY and SHR animals. EEAP 
did not have cytotoxic effects or cause chromosomic alterations. The AHE shown by EEAP could result 
from its endothelium-dependent vascular action. Rutin-like flavonoids, among other polyphenols, could 
contribute to these biological activities, and the calcium present in EEAP could act in a synergistic way.
Uniterms: Alpinia. Alpinia purpurata/phytochemistry. Alpinia purpurata/ethanolic extract/vascular 
reactivity. Alpinia purpurata/ethanolic extract/acute hypotensive effect. Flavonoids/quantification. 
Polyphenols/quantification.
Os objetivos deste estudo foram avaliar o perfil químico de folhas de Alpinia purpurata K. Schum (AP), 
assim como a reatividade vascular e o efeito hipotensor agudo (EHA) do extrato etanólico de folhas de 
AP (EEAP). Avliou-se o perfil químico utilizando-se HPLC-UV, ICP-OES e quantificação colorimétrica 
de flavonoides e polifenóis totais. A reatividade vascular foi determinada utilizando leito mesentérico 
isolado de ratos WKY. Curvas dose-resposta do EEAP e do material inorgânico da AP (IAP) foram 
realizadas em animais SHR e WKY. Determinaram-se a segurança citotóxica e mutagênica pelo teste 
de micronúcleos. Flavonoides tipo rutina foram quantificados no EEAP (1,8±0,03%) e flavonoide total 
e polifenóis foram de 4,1±1,8% e 5,1±0,3%, respectivamente. Observou-se ação vasodilatadora do 
EEAP, mediada parcialmente pelo óxido nítrico (·NO). O IAP revelou a presença de cálcio (137,76±4.08 
μg.mg-1 de Ca). O EEAP e IAP apresentaram EHA em animais WKY e SHR. Não se observaram efeitos 
citotóxicos e alterações cromossômicas provocadas pelo EEAP. O EEAP mostrou um EHA que poderia 
resultar de ação vascular dependente do endotélio. Rutina, entre outros polifenóis e flavonoides, poderia 
estar contribuindo para essas atividades biológicas e o cálcio presente no EEAP, poderia agir de maneira 
sinérgica.
Unitermos: Alpinia. Alpinia purpurata/fitoquímica. Alpinia purpurata/extrato etanólico/reatividade 
vascular. Alpinia purpurata/extrato etanólico/efeito hipotensor agudo. Flavonoides/quantificação. 
Polifenóis totais/quantificação.
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INTRODUCTION
With the increasing life expectancy of the general 
population, there is an increased prevalence of many 
chronic diseases, such as hypertension (Fuchs et al., 
2001). Hypertension is characterized by maintenance 
of sustained high blood pressure levels (above 140/80 
mmHg) (Chobanian et al., 2003; WHO, 2003), and it 
contributes significantly to serious complications such as 
stroke, myocardial infarction, congestive heart failure, and 
chronic renal failure (WHO, 1999; Chobanian et al., 2003; 
WHO, 2003; Kaplan, Opie, 2006; Thayer, Lane, 2007).
Endothelial dysfunction plays an important role 
in hypertension (i.e., elevated blood pressure) and 
contributes to complications in patient condition (Higashi 
et al., 2002). The role of the endothelium is of particular 
importance, since it regulates vascular smooth muscle 
tone and the release of relaxing factors (Török, 2000) 
such as nitric oxide (·NO), prostacyclin, and endothelium-
derived hyperpolarizing factor (EDHF; Luksha, Agewall, 
Kublickiene, 2009).
Several studies have demonstrated medicinal plants’ 
effects on blood pressure by various mechanisms, such 
as increased release of ·NO and EDHF (Rocha et al. 
2007; Victório et al., 2009a; Khan et al., 2012; Senejoux 
et al., 2012). The hydroalcoholic and aqueous extracts 
(De Moura et al., 1998) and essential oils (Victório, 
Kuster, Lage, 2009b; Barcelos et al., 2010) of the Alpinia 
zerumbet (Pers.) Burtt et Smith (AZ) have been reported 
to promote a hypotensive effect. Another species of 
Alpinia, the Alpinia purpurata (Vieill) K. Schum (AP), 
shows phytochemical similarity with AZ in terms of the 
composition of its essential oil (Victório et al., 2009a) 
and the presence of flavonoids therein (Victório, Kuster, 
Lage, 2009c).
Mladenka et al. (2010) revised the benefits of 
flavonoids in the prevention and treatment of cardiovascular 
diseases, reporting their capacity to reduce blood pressure 
in hypertensive rats without any normotensive effect. 
Victório et al. (2009a) reported that the hydroalcoholic 
extract of AP leaves is rich in flavonoids and can elicit 
relaxation of the mesenteric vascular bed. However, the 
participation of relaxant factors from the endothelium in 
this action (and their hypotensive effects) have not been 
evaluated yet.
We hypothesized that AP’s vasodilatory action 
results in the hypotensive effect via an endothelium-
dependent mechanism. Therefore, the purposes of the 
present study were to evaluate the mesenteric vascular bed 
reactivity with and without pharmacological blockade of 
relaxant factors from the endothelium and the hypotensive 
effect of the ethanolic extract of AP leaves, its cytotoxic 
and mutagenic safety, and its chemical profile using 
HPLC-RP, ICP-OES, and colorimetric quantification of 
total flavonoids and polyphenols.
MATERIAL AND METHODS
Plant material
Alpinia purpurata (Vieill) K. Schum was collected 
in August 2010 in Garden City Park in Maruípe, Vitória, 
Espirito Santo and identified by Profa. M.Sc. Solange Z. 
Schneider, botanic of the herbarium at the University Vila 
Velha (UVV), where a voucher specimen is deposited 
under the number UVVES 2036.
Chemical material
All referenced chemicals and substances, unless 
otherwise specified were purchased from Sigma-Aldrich 
Chemical Co. (St Louis, MO, USA). Ultrapure water was 
used in all stages (ELGA purifier, 18.2 W).
Extraction and isolation
The leaves of the plant were dried and ground. 
The dried material was submitted to ultrasound-assisted 
extraction with ethanol (0.6 g mL-1) at room temperature. 
The solvent was removed in a rotary evaporator (Fisatom) 
at 50 °C, yielding a greenish residue (8.2 g, EEAP). The 
EEAP was mixed in water and submitted to partition with 
dichloromethane and buthan-1-ol, yielding three fractions: 
dichloromethane extract, buthanolic extract, and an aqueous 
fraction (0.2 g, 4.0 g, and 1.0 g, respectively). Based on the 
available mass and thin layer chromatography profile, the 
buthanolic fraction was selected for fractionation. After its 
dispersion in methanol, the formed precipitate was removed 
by centrifugation at 8460 g, affording 1.5 g of a colorless 
crystalline precipitate. The soluble part of the buthanolic 
fraction (2.1 g) was concentrated.
Spectroscopic methods
Determination of metal content was performed in an 
inductively coupled plasma optical emission spectrometer 
(ICP-OES; Varian model 720) with ICP Expert II software 
for data analysis. The infrared (IR) spectra were obtained 
on a Perkin Elmer spectrophotometer model Spectrum BX 
79589 at room temperature. The spectra were obtained by 
diluting the sample in a 1% solution of potassium bromide 
(KBr).
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Determination of water matter in the inorganic 
material isolated from the 1-buthanol fraction of 
A. purpurata (IAP)
The water matter content of the IAP was determined 
by the gravimetric method (USP, 2006). Analyses were 
performed in triplicate, and the results were expressed as 
the percentage ± standard deviation (SD) in relation to the 
respective dry plant.
Determination of metal in the ethanolic extract of 
A. purpurata (EEAP), plant drug, and IAP
EEAP, IAP, and dry plant samples were digested 
with Merck ultrapure grade 65% nitric acid and 37% 
hydrochloric acid (HNO3, HCl, 8:3) at 80 °C until the 
solution became transparent. The residues were transferred 
to 25 mL flasks and diluted to a final defined volume 
using a 2 M solution of nitric acid. The samples were 
analyzed for 10 elements: silver, aluminum, barium, 
beryllium, bismuth, calcium, cadmium, cesium, zinc, and 
magnesium (Ag, Al, Ba, Be, Bi, Ca, Cd, Cs, Zn, and Mg, 
respectively). The analysis was performed on an ICP OES; 
all concentrations were reported as dry weights (mg mg-1).
EEAP chemical profile by high-performance liquid 
chromatography (HPLC-RP)
EEAP samples were solubilized in methanol 
(MeOH) at a concentration of 10 mg mL-1 by sonication 
for 15 min, followed by centrifugation at 8400 g for 10 
min. Supernatants (20 µL) were injected into HPLC 
equipment (Waters). To obtain sample chromatograms, 
isocratic elution with a solvent mixture of MeOH:H2O 
(95:5) was employed in an XBridgeTM-18 column (5 µm, 
250 × 4 mm id). The chromatograms were recorded at 
two wavelengths (254 and 365 nm), a flow rate of 0.8 
mL min-1, and room temperature. The Breeze software 
package was used for data processing. A run with co-
injection of rutin at 0.048 µg mL-1 was performed for 
confirmation of the type of substance in the sample. A 
calibration curve of 1.95, 3.90, 7.80, 15.6, 31.3, 62.5, 
125, and 250 µg mL-1 of the reference rutin substance was 
constructed. Quantification was performed by external 
curve with 5 points. The following validation parameters 
were evaluated: linearity, precision, and limits of detection 
and quantification. Repeatability was evaluated with 
seven consecutive assays. The limits of detection and 
quantification were determined by the levels of signal 
and noise three and six times, respectively. The equation 
of the line obtained by linear regression for the standard 
curve was y = 54,340,468.67 x - 18,738.54, r2 = 0.9967. 
The linear range was 3.9–125 µg mL-1, with a detection 
limit of 4.83 µg mL-1 and a quantification limit of 16.12 
µg mL-1. The results were expressed as mg of flavonoids 
per 100 mg of sample (%).
Determination of total polyphenols in plant drug 
and EEAP
The polyphenol content was determined using 
the Folin-Ciocalteu method with modifications 
(Purwantiningsih, Hussin, Chan, 2011; Singleton, Rossi, 
1965). Solutions were prepared quantitatively with 
sample concentrations of 1.5 mg mL-1 (extract) and 25 
mg mL-1 (plant drug). The absorbance was measured at 
750 nm using a spectrophotometer with a methanol blank 
solution. A calibration curve was prepared with solutions 
of pyrogallol (10-350 µg mL-1); its equation was y = 
0.001244 x + 0.002889, r2 = 0.9977. The results were 
expressed as µg of pyrogallol equivalents (PE) per mg of 
sample. Analyses were performed in triplicate.
Determination of total flavonoids in plant drug 
and EEAP
The colorimetric method employing aluminum 
chloride (AlCl3; Marinova, Ribarova, Atanassova, 
2005; El-Beltagi, Salama, El-Hariri, 2007) was used for 
determination of total flavonoids in these samples. For this 
assay, 1 mL of each sample solution (1.5 mg mL-1 and 25 
mg mL-1 for the extract and plant drug, respectively) was 
used. Absorbance was measured by spectrophotometer 
(T80+UV/VIS Spectrometer, PG Instruments, Ltd.) at 
415 nm. The calibration curve was prepared with solutions 
of rutin ranging between 31.25-1000 µg mL-1 and had 
the equation y = 0.0033 x + 0.0121, r2 = 0.9991. The 
results were expressed as µg of rutin equivalents (RE) 
per milligram of sample. Analyses were performed in 
triplicate.
Animals
The an imal  exper iments  were  per formed 
in accordance with the ethical principles for animal 
experimentation prepared by the Brazilian College of 
Animal Experimentation (COBEA, 1991) and were 
approved by the Ethics Committee, Bioethics and Animal 
Welfare of UVV (CEUA-UVV; Protocol 120/2010). The 
experimental groups were composed of spontaneously 
hypertensive rats (SHR, n = 18) and their normotensive 
controls (Wistar-Kyoto rats [WKY], n = 18); they were 
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housed in individual cages with wood shavings (23 °C and 
a 12-h light–dark cycle). All animals had access to food 
(Probiotério diet, Moinho Primor, SA) and water ad libitum.
Evaluation of the Mesenteric bed of the EEAP
The superior mesenteric artery and its branches were 
isolated and perfused with a warmed (37 °C), gassed (5% 
CO2 in 95% O2) physiological salt solution composed 
of 130 mM NaCl, 4.7 mM KCl, 1.6 mM CaCl2·2H2O, 
1.17 mM MgSO4·6H2O, 14.9 mM NaHCO3, 1.18 mM 
KH2PO4, 0.026 mM EDTA, and 11.1 mM glucose, pH 
7.4. Perfusion was maintained at a constant rate of 4 mL/
min with a roller pump, and the perfusion pressure was 
recorded using a pressure transducer coupled to a MP-100 
System Guide (model MP100-CE; Biopac Systems, Santa 
Barbara, CA, USA). After a stabilization period of 30 min, 
basal perfusion pressure and dose-response curves were 
measured with EEAP (-0.7, -0.4, -0.1, 0.2, 0.49, 0.79, 
and 1.09 log [mg mL-1]) in mesenteric bed precontracted 
with norepinephrine (2.5–10µM, in order to achieve 
stable perfusion pressures of 120–150 mmHg). One dose 
of acetylcholine (ACh; -0.6 log [mg mL-1]) was used to 
evaluate the integrity of the endothelium.
Influence of relaxant factor from endothelium on 
EEAP’s vascular action
Concentration-response curves to EEAP were 
determined before and after 30 min preincubation with 
the NOS inhibitor NG-nitro-L-arginine methyl ester 
(L-NAME; 100 mol L-1), L-NAME plus indomethacin 
(2.8 × 10-6 mol L-1), or L-NAME plus indomethacin and 
clotrimazole (10 mol L-1) to evaluate the participation of 
·NO, prostaglandin, and EDHF, respectively.
Surgical procedures and hemodynamic records
A polyethylene catheter (PE 50, Clay Adans®, 
USA) was connected to the femoral artery and vein. An 
incision was made in the inguinal region, under anesthesia 
with sodium pentobarbital (50 mg kg-1, intra-peritoneal 
Hypnol®, Crystal, Brazil), with the subsequent isolation 
of the vascular plexus nerve to allow catheterization. 
Mean arterial pressure (MAP) and heart rate (HR) were 
measured in conscious animals 24 h later using a pressure 
transducer (Model PT 300, Grass Instrument Div., 
Warwick, NY, USA) coupled to a Biopac System (MP100, 
Santa Barbara, CA, USA). The catheter in the femoral 
vein was used to inject the various doses of EEAP or IAP 
solutions or saline.
Evaluation of the acute hypotensive effects of the 
EEAP and IAP
The hypotensive effect was evaluated via dose-
effect curves for the EEAP and IAP. WKY and SHR 
animals received saline (1 mL kg-1) as a negative control 
to establish a baseline (Soncini et al., 2011), and they 
then received increasing doses of the EEAP (0.1–100 
mg kg-1) or IAP (0.01–10 μg kg-1), both dissolved in 
saline (0.9% NaCl). Subsequent doses were injected only 
after MAP levels returned to baseline. We evaluated the 
maximum percentage decrease in MAP after each dose. 
Acetylcholine (ACh) was used as a positive control (5 μg 
kg-1, i.v.; Lahlou et al., 2003) before and after EEAP or 
IAP administration.
In vivo micronucleus test of EEAP
All micronucleus assays, from bone marrow 
specimen collection to slide preparation, were run as 
described by Ribeiro (2003) following the guidelines 
recommended by the Guideline for the Testing of 
Chemicals (OECD, 1997). Additionally, this evaluation 
was performed by a biologist who was blind to the 
experimental group assignment.
Chromosome alteration and cytotoxicity assay
WKY rats of both sexes were divided into three 
experimental groups (n = 5 each). Group A, the negative 
control (NC), received only the vehicle. Group B, the 
positive control (PC40), received cyclophosphamide 
(40 mg kg -1 rat) 24 h before euthanasia. Group C 
was treated with EEAP (n = 5, 100 mg kg-1) by oral 
gavage at 60 h, 48 h, 36 h, and 24 h before euthanasia. 
Chromosome alteration was evaluated by the number of 
polychromatic erythrocytes with micronucleus (PCEMN) 
and cytotoxicity by the mitotic index (the polychromatic/
normochromatic erythrocytes ratio [PCE/NCE]).
Statistical analysis
The values for biological evaluation of the EEAP 
and IAP were expressed as the mean ± standard error of 
mean (SEM), and those of the micronucleus test as the 
mean ± SD. The values for baseline MAP and HR, changes 
in MAP produced by EEAP and IAP, and micronucleus 
test data were submitted to one-way analyses of variance 
(ANOVAs) followed by post-hoc Tukey tests for multiple 
comparisons. To assay vascular reactivity, the data were 
submitted to two-way ANOVAs followed by Bonferroni 
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tests. Differences were considered significant when p < 05.
The chemical analysis was evaluated using 
correlation coefficients with the standard curves gathered 
by linear regression using the least squares method; 
the data were then analyzed by ANOVAs with a 95% 
confidence limit and n – 1 degrees of freedom.
RESULTS AND DISCUSSION
The quantification of total flavonoids in the plant 
drug and extract (Table I) indicates that these metabolites 
were enriched in the ethanolic extract. The EEAP showed 
a simple chromatographic profile, and after co-injection of 
the sample with the flavonoid rutin (Figure 1), the presence 
of rutin-like flavonoids was suggested. The quantification 
results indicated 1.8% ± 0.03% (mg mg-1) of rutin-like 
content in the extract (obtained by HPLC analysis). The 
presence of rutin and other flavonoids was observed in 
other studies conducted with the Alpinia genus, species AP 
and AZ (Mpalatinos et al., 1998; Victório, Kuster, Lage, 
2009c). Rutin was detected in chromatographic profiles 
of the aqueous extract of AZ (Mpalatinos et al., 1998), 
hydroethanolic extracts from AZ and AP, and extracts of 
AP leaves in ethyl acetate (17.8 mg g-1) and butanol (356 
mg g-1) (Victório, Kuster, Lage, 2009c). Several factors 
may influence the content of secondary metabolites, such 
as seasonality, temperature, water availability, and soil 
nutrients, which may explain the differences between the 
levels of flavonoids reported by other authors (Gobbo-
Neto, Lopes, 2007) and those found in this study. We also 
observed a significant enrichment of polyphenols in AP 
leaves and EEAP (Table I). A similar result was observed 
by Victório et al. (2009a) using the same method of 
quantification (30.1 ± 1.8 µg EP mg-1).
Analysis of the infrared spectrum revealed the 
inorganic nature of the IAP: bands assigned to C–H 
stretching (2900-2800 cm-1) and C–C stretching (800 cm-1) 
were absent (Maitz et al., 2002; Boonchom, Danvirutai, 
2009; Kanchana, Sundaramoorthi, Jeyanthi, 2009). 
Phosphates were suggested by the strongest vibrational 
symmetric mode for the P–O bond of the (PO4
3-) group 
at 1100 cm-1; the intense band centered at 960 cm-1 
was attributed to the asymmetric stretch of PO4
3-, and a 
band centered at 540 cm-1 was attributed to the angular 
deformation of PO2 in the phosphate group (Boonchom, 
Danvirutai, 2009). The infrared spectrum of IAP (Figure 
2) was similar to the spectrum of an ethanolic solution of 
calcium phosphate shown by Boonchom and Danvirutai 
(2009).
The ICP-OES analysis identified calcium (137.76 
± 4.08 μg mg-1) as the main metal constituent. Other 
metals (Ba, Be, Bi, Cd, Cs, Ag, Mg and Zn) were below 
the detection limit, except for Al, which presented at a 
concentration of 0.71 ± 0.16 μg mg-1. As the infrared 
spectrum showed that PO4
3- was present, it was inferred 
that IAP is constituted predominantly of calcium 
phosphate (Ca3[PO4]2).
Detection of Ca2+ in the plant drug and EEAP was 
also performed, and as was the case with IAP, that was the 
metal with the highest concentration. However, given the 
TABLE I - Quantification of total polyphenols and flavonoids in Alpinia purpurata leaves and ethanolic extract of AP (EEAP)
Assay Vegetal material (%) EEAP (%) LOQ (µg mL-1) LOD (µg mL-1)
Total polyphenols (mg PE 100 mg-1) 0.7 ± 0.1 5.1 ± 0.3 13.7 4.1
Flavonoids (mg RE 100 mg-1) 1.3 ± 0.1 4.1 ± 1.8 5.3 1.6
LOQ: limit of quantification; LOD: limit of detection; PE; pyrogallol equivalent; RE: rutin equivalent.
FIGURE 1 - Chromatograms of the ethanolic extract of Alpinia purpurata (EEAP). In A, the concentration of EEAP was 5 mg mL-1; 
in B, the concentration of EEAP was 5 mg mL-1 + 0.048 mg mL-1 rutin. Solvent: MeOH:H2O (95:05); flow rate: 0.8 mL min
-1, 254 nm.
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complexity of the matrices of the plant drug and the EEAP, 
the values were 18.85 ± 27.14 μg mg-1 and 15.93 ± 26.45 
μg mg-1, respectively.
The mesenteric bed baseline perfusion pressure 
was 30.3 ± 1.2 mmHg. Acetylcholine induced mesenteric 
bed relaxation (77 ± 2%). EEAP produced concentration-
dependent mesenteric bed relaxation in the rats (Figure 3). 
After L-NAME was added to the perfusion fluid, the 
relaxation was greatly reduced at all doses, whereas 
when both indomethacin and L-NAME were added, this 
reduction was maintained. However, after clotrimazole 
was added in conjunction with the latter two blockers, the 
response to EEAP was abolished.
Endothelium-dependent relaxations are achieved 
by a combination of endothelium-derived prostacyclin 
(PGI2), nitric oxide (·NO), and endothelium-derived 
hyperpolarizing factor (EDHF; Shimokawa et al., 1996; 
Huang et al., 2001). The results of this study indicate the 
importance of ·NO, but not prostanoids, in the dilating 
response to EEAP. Additionally, the addition of the 
CYP inhibitor clotrimazole to the nutrition solution with 
L-NAME and indomethacin abolished EEAP-induced 
vasodilation. CYP generates epoxyeicosatrienoic acids, 
metabolites of arachidonic acid that have been suggested 
to contribute to the EDHF response in animal and human 
vessels, as they induce the hyperpolarization of endothelial 
and smooth muscle cells (Busse et al., 2002; Taddei et al., 
2006; Yanga, Yima, He, 2007).
As the vascular relaxant action of EEAP was 
FIGURE 2 - Infrared spectrum of the inorganic material isolated 
from the butan-1-ol fraction of A. purpurata (IAP).
FIGURE 3 - Mesenteric vascular reactivity of EEAP. Panel A: concentration-effect curves of EEAP and EEAP + L-NAME. Panel 
B: concentration-effect curves of EEAP and EEAP + L-NAME + indomethacin (Indo). Panel C: concentration-effect curves of 
EEAP and EEAP + L-NAME + indo + clotrimazole (Clo). Values are expressed as the mean ± SEM. **p < 0.01 and ***p < 0.001 
compared with values of EEAP with blocking.
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FIGURE 4 - Percentage decrease in MAP after injection of saline (1 mL kg-1) and increasing doses of EEAP (0.1–100 mg kg-1; 
Panel A) and IAP (0.01–10 mg kg-1; Panel B). Values are expressed as the mean ± SEM. **p < 0.01 compared with WKY animals.
determined, we investigated whether a hypotensive 
effect could be elicited by EEAP in vivo. We also tested 
whether the IAP elicits blood pressure reduction. In in vivo 
experiments, as expected, the SHR showed high levels 
of MAP (155 ± 4 mmHg, p < 0.01) compared with WKY 
rats (102 ± 3 mmHg). However, there was no difference 
in baseline HR (WKY: 365 ± 10 bpm; SHR: 378 ± 11 
bpm) between groups of rats. Figure 4 shows the acute 
hypotensive effects of the EEAP and IAP, which elicited 
dose-dependent reductions in MAP in both normotensive 
(EEAP: -26 ± 2%; -30 ± 3%; -43 ± 4%; -54 ± 2%; -63 ± 
5%; IAP: -13 ± 3%; -16 ± 3%; -20 ± 2%, -26 ± 2%; -30 ± 
1%) and hypertensive (EEAP: -36 ± 3%; -45 ± 4%; -58 ± 
3%; -70 ± 2%; 93 ± 5%; IAP: -18 ± 4%; -23 ± 2%; -32 ± 
2%; -36 ± 1%, -46 ± 1%) rats. The values differed from 
the reduction elicited by saline (WKY: -7 ± 3%; SHR: -8 
± 4%) at all doses of EEAP and all but the weakest dose 
of IAP. Additionally, blood pressure reduction was higher 
in magnitude in SHR than in normotensive animals (p < 
.01) at all doses of EEAP, and in all but the two weakest 
doses of the IAP. Several studies have shown a blood 
pressure-lowering effect of AZ, a species very similar 
to AP (Mendonça et al., 1991; Mpalatinos et al., 1998; 
Lahlou et al., 2002, 2003; De Moura et al., 2005; Barcelos 
et al., 2010). The study by Mendonça et al. (1991) 
demonstrated an important blood pressure-lowering effect 
of the alcoholic extract of AZ in rats. Lahlou et al. (2002) 
observed that i.v. treatment with the essential oil of AZ 
induces immediate and significant hypotension in rats. 
Barcelos et al. (2010) found that chronic treatment with 
the essential oil of AZ reduced MAP in SHR animals. 
However, no studies have evaluated the hypotensive 
effect of AP.
Acetylcholine induced a hypotensive effect 
both before and after the dose-effect curves of the 
EEAP and IAP were measured (WKY: -45 ± 5% and 
-43 ± 3%, respectively; SHR: -53 ± 3% and -51 ± 
2%, respectively), indicating vascular integrity. This 
measurement was important, since vascular relaxation 
induced by acetylcholine is dependent on the integrity 
of the endothelial cells (Batlouni, 2001; Victório et al., 
2009a).
Victório et al. (2009a) reported the vasodilatory effect 
of the hydroalcoholic extract of AP in mesenteric bed from 
Wistar rats pre-contracted with norepinephrine. However, 
the role of the endothelium in this effect was not evaluated. 
To our knowledge, the present study’s data demonstrate 
for the first time that EDHF and ·NO participate in the 
acute relaxing response to EEAP in the isolated perfused 
mesenteric bed, and that the same extract can elicit an in vivo 
hypotensive effect. The involvement of the ·NO pathway 
in the vasodilatory action (i.e., hypotensive effect) has 
been reported in AZ. De Moura et al. (2005) demonstrated 
that vasodilatation induced by the extract of AZ (AZE) is 
dependent on ·NO release; further, they showed that the anti-
hypertensive effect on DOCA-salt hypertensive animals 
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can be caused by a reduction in vascular resistance induced 
by a substantial increase in ·NO production by endothelial 
cells. Lahlou et al. (2003) found in their study that the 
hypotensive response to AZ’s essential oil is due to active 
vascular relaxation.
An interesting finding in our study was the 
determination of calcium levels in the EEAP. Considering 
the evidence that dairy products and green vegetables 
rich in calcium can prevent blood pressure elevation, 
the acute hypotensive effect of IAP was also evaluated. 
The results showed that IAP can reduce blood pressure 
in both normo- and hypertensive animals. Mäkynen et 
al. (1995) suggested that the reduction of blood pressure 
associated with increased dietary intake of calcium is 
induced by increased arterial relaxation. Furspan et al. 
(1989) and Dominiczak et al. (1991) observed strong 
evidence that increased extracellular calcium causes 
reduction in vascular contractility, but stabilization of the 
vascular membrane. Therefore, the calcium in EEAP could 
act synergistically with other compounds to determine 
both the vasodilatory action and the hypotensive effect 
observed with the administration of EEAP.
We identified the presence of polyphenols and 
flavonoids in EEAP. Studies have reported the involvement 
of polyphenols in endothelium-dependent relaxant 
effects mediated by the liberation of ·NO and EDHF 
(Andriambeloson et al., 1997; De Moura et al., 2002; 
Ndiaye et al., 2003; De Moura et al., 2004). Senejoux et 
al. (2012) demonstrated the possibility that polyphenolic 
compounds found in the extract of Nitraria sibirica 
Pall fruit are involved in its hypotensive properties and 
endothelium-dependent relaxation effects; these mainly 
involve ·NO liberation, EDHF, and stimulation of the 
muscarinic receptors.
Among the polyphenolic compounds, flavonoids 
have been widely identified and studied (Ramassamy, 
2006). A recent study reviewed the role and importance 
of flavonoids in the prevention of cardiovascular diseases. 
Reported beneficial effects include inhibition of oxidation 
of low-density lipoprotein (LDL), antiplatelet activity, 
anti-inflammatory effects, antioxidant effects, and a 
hypotensive effect with direct vasodilation (Majewska-
Wierzbicka, Czeczot, 2012). Mpalantinos et al. (1998) 
suggested that the anti-hypertensive and diuretic activities 
of AZ extract are caused by the presence of flavonoids.
Rutin-like flavonoids were identified and quantified 
in the EEAP. Ferreira et al. (2007) demonstrated that 
rutin is a major flavonoid found in ethanolic extracts 
of Hancornia speciosa Gomes, and that it contributes 
to endothelium-dependent vasodilator activity in rat 
mesenteric artery. Additionally, Lapa Fda et al. (2011) 
showed that Polygala paniculata L. extract induces 
potent vasodilatory action and hypotensive effects via 
the ·NO pathway and that these effects are related to 
rutin. Therefore, the presence of polyphenols such as 
flavonoids (especially rutin) in the EEAP should account 
for its endothelium-dependent vasodilatory action and its 
hypotensive effect by releasing ·NO and EDHF.
The results of the micronucleus test are shown 
in Table II. The EEAP, at the dose used (100 mg kg-1), 
induced no chromosome alterations. There was no 
significant difference (p > 0.01) between MNPCE and 
the negative control, but significant differences (p < 0.01) 
compared with the positive control (PC40). The result 
is considered positive for mutagenicity only if the test 
group shows a statistically significant increase in the 
frequency of treatment-related MNPCE at any sampling 
time (Ribeiro, 2003). The EEAP also did not show any 
cytotoxic activity, since the group treated with EEAP 
showed a significant difference (p < 0.01) in the PCE/NCE 
ratio relative to the PC40 group. However, that group’s 
results were not different from those of the NC group. 
Thus, these data indicated that the EEAP has no cytotoxic 
activity (Ribeiro, 2003; Leite et al., 2006).
TABLE II - Numbers of normochromatic erythrocytes (NCE), polychromatic erythrocytes (PCE), and micronucleated polychromatic 
erythrocytes (MNPCE) and the polychromatic erythrocytes/normochromatic erythrocytes (PCE/NCE) ratio in the bone marrow 
of rats treated with  the ethanolic extract of A. purpurata (EEAP) in 0.9% saline solution
Group NCE PCE MNPCE PCE/NCE
NC 92.0 ± 17.6 109.2 ± 16.9 1.5 ± 1.3 1.25 ± 0.40
PC40 146.2 ± 17.4** 54.2 ± 17.1** 13.4 ± 3.4** 0.39 ± 0.17**
EEAP 91.2 ± 12.3## 106 ± 9.8## 1.6 ± 0.9## 1.18 ± 0.21##
NC: negative control; PC40: positive control (cyclophosphamide 40 mg kg-1); EEAP (100 mg kg-1): group treated with the EEAP 
in the 0.9% saline solution. The values are expressed as the mean ± standard deviation (SD). **p < 0.01 compared with negative 
control and ##p < 0.01 compared with the positive control. We performed one-way analyses of variance (ANOVAs) followed by 
post hoc Tukey tests.
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In conclusion, the EEAP presented an acute 
hypotensive effect,  which could result  from its 
endothelium-dependent vascular action. Rutin, among 
other polyphenols and flavonoids, could contribute to these 
biological activities, and it is possible that the calcium 
present in EEAP (determined to be calcium phosphate 
in IAP isolated from EEAP) could act synergistically. 
Additionally, EEAP caused no chromosome alterations 
or cytotoxic effects.
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